JP Morgan Maintains Neutral on Mednax, Lowers Price Target to $26

JP Morgan maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $29 to $26.

Benzinga · 11/07/2019 13:15

JP Morgan maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $29 to $26.